Skip to Main content Skip to Navigation
Journal articles

Molecular Actions of PPARα in Lipid Metabolism and Inflammation

Abstract : Peroxisome proliferator-activated receptor α (PPARα) is a nuclear receptor of clinical interest as a drug target in various metabolic disorders. PPARα also exhibits marked anti-inflammatory capacities. The first-generation PPARα agonists, the fibrates, have however been hampered by drug-drug interaction issues, statin drop-in, and ill-designed cardiovascular intervention trials. Notwithstanding, understanding the molecular mechanisms by which PPARα works will enable control of its activities as a drug target for metabolic diseases with an underlying inflammatory component. Given its role in reshaping the immune system, the full potential of this nuclear receptor subtype as a versatile drug target with high plasticity becomes increasingly clear, and a novel generation of agonists may pave the way for novel fields of applications.
Document type :
Journal articles
Complete list of metadata

Cited literature [74 references]  Display  Hide  Download
Contributor : Marie-Hélène Derudas Connect in order to contact the contributor
Submitted on : Wednesday, June 12, 2019 - 8:26:31 AM
Last modification on : Wednesday, November 3, 2021 - 2:57:03 PM


Bougarne Endocrine Review.pdf
Files produced by the author(s)




Nadia Bougarne, Basiel Weyers, Sofie Desmet, Julie Deckers, David Ray, et al.. Molecular Actions of PPARα in Lipid Metabolism and Inflammation. Endocrine reviews, Endocrine Society, 2018, 39 (5), pp.760-802. ⟨10.1210/er.2018-00064⟩. ⟨inserm-02153118⟩



Les métriques sont temporairement indisponibles